- Home
- LSAK vs HQL Comparison
LSAK vs HQL Comparison
Compare LSAK & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSAK
- HQL
- Stock Information
- Founded
- LSAK 1997
- HQL 1992
- Country
- LSAK South Africa
- HQL United States
- Employees
- LSAK N/A
- HQL N/A
- Industry
- LSAK Investment Bankers/Brokers/Service
- HQL Investment Managers
- Sector
- LSAK Finance
- HQL Finance
- Exchange
- LSAK Nasdaq
- HQL Nasdaq
- Market Cap
- LSAK 344.5M
- HQL 378.8M
- IPO Year
- LSAK N/A
- HQL N/A
- Fundamental
- Price
- LSAK $4.75
- HQL $13.73
- Analyst Decision
- LSAK
- HQL
- Analyst Count
- LSAK 0
- HQL 0
- Target Price
- LSAK N/A
- HQL N/A
- AVG Volume (30 Days)
- LSAK 29.5K
- HQL 120.9K
- Earning Date
- LSAK 09-03-2025
- HQL 01-01-0001
- Dividend Yield
- LSAK N/A
- HQL 11.56%
- EPS Growth
- LSAK N/A
- HQL N/A
- EPS
- LSAK N/A
- HQL 0.79
- Revenue
- LSAK $574,080,000.00
- HQL N/A
- Revenue This Year
- LSAK $1.06
- HQL N/A
- Revenue Next Year
- LSAK $13.32
- HQL N/A
- P/E Ratio
- LSAK N/A
- HQL $17.08
- Revenue Growth
- LSAK 4.13
- HQL N/A
- 52 Week Low
- LSAK $3.39
- HQL $11.34
- 52 Week High
- LSAK $5.60
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- LSAK 59.48
- HQL 66.15
- Support Level
- LSAK $4.50
- HQL $13.05
- Resistance Level
- LSAK $4.75
- HQL $13.31
- Average True Range (ATR)
- LSAK 0.27
- HQL 0.19
- MACD
- LSAK 0.02
- HQL 0.01
- Stochastic Oscillator
- LSAK 100.00
- HQL 100.00
About LSAK Lesaka Technologies Inc.
Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.